Larvol Delta - Biora-Therapeutics-Achieves-Positive-Interim-Results-for-Clinical-Trial-of-BT600-Advancing-NaviCap-Platform-Development

liquid tofacitinib delivered by DDS (BT-600) - Biora Therap

https://www.globenewswire.com/news-release/2024/04/04/2857705/0/en/Biora-Therapeutics-Achieves-Positive-Interim-Results-for-Clinical-Trial-of-BT-600-Advancing-NaviCap-Platform-Development.html

Apr 4, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next